National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 2,281 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died



Case Details (Sorted by Age)

This is page 9 out of 229

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next


VAERS ID: 1037312 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166343

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the third of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. Patient medical history and concomitant medical history were not reported. An outbreak of covid-19 infection in the retirement home where the physician was working, was reported on 22Jan2021. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. Follow-up attempts are not possible. No further information is expected. Information on lot number cannot be obtained.; Sender''s Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 same reporter, product and event; different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037313 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166344

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the fourth of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (COVID-19) with COMIRNATY use can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: COVID-19


VAERS ID: 1037314 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166345

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned; Contamination spread to 34 residents and 13 deaths to be mourned; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the fifth of thirteen reports. A patient of unspecified age and gender started to received BNT162B2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. On 22Jan20211, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on 22Jan2021 with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned; Contamination spread to 34 residents and 13 deaths to be mourned


VAERS ID: 1037315 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166346

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned/patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned/patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the sixth of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, solution for injection, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. Follow-up attempts are not possible. Information on the batch/lot number cannot be obtained. No further information is expected.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective at the time of onset of COVID 19 infection, based on the information provided. There is limited information provided in this report. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 same reporter, product and event; different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned/patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned/patient had COVID-19 with fatal outcome


VAERS ID: 1037316 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166347

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the seventh of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at a single dose for Covid-19 immunization. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on 22Jan2021 with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037317 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166348

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the 8th of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (fatal COVID-19) with COMIRNATY use can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037318 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166349

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the ninth of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient had COVID-19 on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (fatal COVID-19) with COMIRNATY use can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 same reporter, product and event; different patient.; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037319 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166350

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the tenth of thirteen reports. A patient of unspecified age and gender started to receive bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037320 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166351

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the eleventh of thirteen reports. A patient of unspecified age and gender received BNT162B2 (COMIRNATY; lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 as a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of COVID-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on 22Jan2021 with a fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID-19 based on the known safety profile. However the short duration of 11 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037321 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166352

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the 12th of thirteen reports. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on 22Jan2021 with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID-19 based on the known safety profile. However the short duration of 11 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter, product and event; different patient.; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=9&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166